Menu

Remagin: Serving Your Eye And Oculofacial Plastic Needs

For over ten years, the teams at Orlando Eye Institute and Parbhu Oculofacial Plastic Surgery have proudly treated the residents of Dr. Phillips and Windermere, serving your eye and oculofacial plastic needs with compassion, respect and professionalism. 

As they have grown, thanks to the support of their patients and their community, they have been able to integrate cutting-edge technologies into the practice and broaden the scope of what they can provide.  This was the concept in fusing the two practices and changing the name to Remagin.  While their commitment to your care remains the same, they can now provide a wider array of treatments, all under one roof, without the restrictions or barriers of conventional thinking. Instead, they want you to concentrate on the things that make you happy and let them help you get there! 

Drs. Parbhu and Raja are both board-certified physicians and believe in providing direct care to their patients.  They perform all procedures and surgeries and provide all perioperative care to patients. All injectable and laser treatments are also performed by Dr. Parbhu. Recent additions include light adjustable lens technology for cataract surgery, corneal cross linking for keratoconus, nonsurgical lower facial rejuvenation, facial fat transfer, and Dr. Parbhu’s own medical grade skincare line.

While the doctors have always been about improving the quality of their patients’ lives, they now have a much clearer vision of how to do so. This allows them to optimize vision, decrease spectacle and eye drop use, bring comfort and instill confidence in your appearance — all in a safe and welcoming environment that their patients have come to expect.  Refine. Refocus. Remagin. 

Deepak Raja, MD and Keshini Parbhu, MD

Remagin (Formerly Orlando Eye Institute and Parbhu Oculofacial Plastic Surgery)

4750 The Grove Drive, Suite 230

Windermere, FL 34786

407-704-3937

www.Remagin.com

shop.remagin.com

Written by Staff Writer

Leave a Reply

Exit mobile version